| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.21B | 50.30B | 51.14B | 49.30B | 47.60B | 46.88B |
| Gross Profit | 11.77B | 11.58B | 11.74B | 11.89B | 11.93B | 12.49B |
| EBITDA | 5.38B | 4.82B | 5.35B | 5.71B | 5.78B | 6.65B |
| Net Income | 3.36B | 2.76B | 3.05B | 3.55B | 3.54B | 4.17B |
Balance Sheet | ||||||
| Total Assets | 41.77B | 42.42B | 41.75B | 39.83B | 36.20B | 33.83B |
| Cash, Cash Equivalents and Short-Term Investments | 19.21B | 17.43B | 20.57B | 20.94B | 18.37B | 16.43B |
| Total Debt | 275.51M | 0.00 | 87.84M | 70.68M | 61.96M | 72.92M |
| Total Liabilities | 8.44B | 8.12B | 8.51B | 8.68B | 7.73B | 8.03B |
| Stockholders Equity | 31.99B | 32.79B | 31.89B | 30.04B | 27.61B | 25.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.01B | 1.23B | 3.72B | 3.25B | -2.24B |
| Operating Cash Flow | 0.00 | 2.79B | 4.37B | 4.49B | 3.55B | 4.03B |
| Investing Cash Flow | 0.00 | -3.94B | -3.33B | -712.00M | -337.99M | -6.10B |
| Financing Cash Flow | 0.00 | -2.07B | -1.42B | -1.24B | -1.31B | -870.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥14.82T | 29.86 | 27.29% | 0.27% | 3.93% | 29.13% | |
75 Outperform | ¥141.66B | 15.08 | ― | 2.38% | 15.54% | 40.98% | |
74 Outperform | ¥34.43B | 11.97 | ― | 3.82% | -1.63% | -8.83% | |
74 Outperform | ¥233.43B | 15.53 | 28.98% | 5.57% | 3.47% | 18.14% | |
69 Neutral | ¥532.63B | 12.37 | 19.18% | 3.59% | 7.21% | 20.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥55.72B | -12.88 | -6.02% | 0.77% | -3.21% | -104.97% |